Cycloxan 1gm Injection

Cyclophosphamide

Uses of Cycloxan 1gm Injection

  • Malignant lymphomas
  • Leukemias
  • Retinoblastoma
  • Carcinoma of breast
  • Ovarian cancer
  • Mycosis fungoides
  • Minimal Change Nephrotic Syndrome in Pediatric Patients

Introduction to Cycloxan 1gm Injection

Cycloxan 1gm Injection is a chemotherapy drug containing the active constituent cyclophosphamide. It is used to treat various malignancies (abnormal production of cells is called cancer, and if they spread to other organs then they are called malignancies). Cycloxan 1gm Injection can be used to treat malignant lymphomas (cancers that start from the lymphatic system of the body- vessels, fluid, and lymphoid tissue) such as Hodgkin’s disease, lymphocytic lymphoma, and mixed-cell type lymphoma.

It is used to treat leukemias, neuroblastoma, ovarian cancer, retinoblastoma, and breast carcinoma. It can also treat Minimal Change Nephrotic syndrome in pediatric patients (kidney disease in which large quantities of protein are lost in urine). Cycloxan 1gm Injection is contraindicated in pregnancy, patients with acute infections, urinary tract infections, urinary outflow obstruction, and bone marrow disorders.

Treatment with this medicine may lead to immune suppression, bone marrow failure, cardiotoxicity, renal toxicity, pulmonary toxicity, and secondary malignancies. Inform your doctor if you have pre-existing kidney disease, immune conditions, cardiac disorders, or liver diseases.

Therapeutic Effects of Cycloxan 1gm Injection

Cycloxan 1gm  Injection Injection slows or stops the growth of cancer cells by damaging the hereditary material (DNA and RNA) of the cancer cells. In nephrotic syndrome, it works by suppressing the body’s immune system.


Interaction of Cycloxan 1gm Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products that you are taking or have taken before the treatment. Certain medications may interact with Cycloxan 1gm Injection and cause potential side effects.


More Information about Cycloxan 1gm Injection

Keep out of sight and reach of children. Store vials below or at 25°C.


How to consume Cycloxan 1gm Injection

Cycloxan 1gm  Injection will be administered intravenously by healthcare professionals experienced in cancer chemotherapy. Do not self-administer.


Safety Advices for Cycloxan 1gm Injection

 

Pregnancy

Cycloxan 1gm Injection can cause fetal harm when administered to a pregnant woman. Inform your physician if you are pregnant or planning to get pregnant before taking this medication. Your physician will instruct you to take it when it is necessary.

 

Breast Feeding

Avoid Cycloxan 1gm Injection if you are breastfeeding. Consult your doctor for potential risks and benefits.

 

Lungs

It is unknown whether Cycloxan 1gm Injection can be given in lung failure patients. Inform your doctor if you have any lung diseases.

 

Liver

Cycloxan 1gm Injection should be used with caution in patients with liver disease. Please consult your doctor.

 

Alcohol

It is unsafe to consume alcohol with Cycloxan 1gm  Injection. Please consult your doctor for more advice.

 

Driving

It is not recommended while driving because it causes dizziness, and patients may lack concentration and alertness.


Side Effects of Cycloxan 1gm Injection

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Serious

  • Infections
  • Immune suppression
  • Blood disorders
  • Allergic reactions
  • Abnormal liver function
  • Inflammation of the bladder
  • Kidney diseases
  • blood in urine
  • sterility
  • impaired wound healing

Common

  • Nausea, vomiting
  • Low white blood cell count
  • Diarrhea
  • Hair loss
  • Fever
  • Weakness
  • Inflammation
  • Dizziness
  • Blurred vision
  • amenorrhea

Brand

Zydus Cadila

Reviews

There are no reviews yet.

Be the first to review “Cycloxan 1gm Injection”

Your email address will not be published. Required fields are marked *

Top